sofidexFor patientsAre you a clinician? Clinical site

Health Library  ›  Tests  ›  Insulin c-peptide test

Test

Insulin c-peptide test

A C-peptide test estimates how much insulin your pancreas is making.

8 min readTestReviewed 2026-08-24

PDF
What it measures
C-peptide released when the pancreas makes insulin
Sample
Blood
Fasting needed?
Sometimes, for fasting or supervised hypoglycaemia testing
How long it takes
About 10 minutes; longer for a stimulation test
Results in
Usually one to several days, varying by laboratory
Used for
Diagnosis and monitoring of the body's own insulin production
Main limitation
Reduced kidney function can falsely raise C-peptide

Overview

A C-peptide test estimates how much insulin your pancreas is producing. Insulin is a hormone that helps glucose, or sugar, move from your blood into your cells.

Your pancreas first makes a larger substance called proinsulin. It then splits proinsulin into insulin and connecting peptide, usually called C-peptide. These are released into the blood in roughly equal amounts.

Injected insulin does not contain C-peptide. This makes C-peptide useful for assessing your body's own insulin production, including when you use insulin as a medicine.

C-peptide remains in the blood longer than insulin and is often easier to measure reliably. However, the result must be interpreted alongside your blood glucose level, kidney function, medicines, and the reason for testing.

Why the test is ordered

The test may be used to find out whether your pancreas is still making insulin. It can help when the type of diabetes is uncertain, particularly after the initial diagnosis or when the clinical picture has changed.

It may also be ordered to:

  • assess remaining insulin production in someone with diabetes
  • help investigate repeated or unexplained low blood glucose
  • distinguish insulin made by the body from injected insulin
  • monitor insulin production after pancreatic surgery
  • contribute to the assessment of a possible insulin-producing pancreatic tumour

C-peptide is not normally used by itself to diagnose diabetes. Blood glucose and HbA1c, which reflects average glucose over the previous two to three months, are more appropriate for that purpose.

Who should have the test

A clinician may suggest C-peptide testing if knowing how much insulin your pancreas makes would affect your diagnosis, monitoring, or treatment plan.

Examples include uncertain diabetes classification, unexpectedly low blood glucose, or a need to assess insulin production after several years of diabetes. It is not usually part of routine diabetes screening.

A result is most useful when there is a clear clinical question and a blood glucose measurement is taken at the same time. Testing without knowing the glucose level can make a low or high C-peptide result difficult to interpret.

How to prepare

Follow the instructions from the service arranging your test. Preparation differs according to why C-peptide is being measured.

You may be asked to fast, often overnight, for a fasting C-peptide test. This means having no food or drinks containing calories. Plain water is generally allowed unless you have been told otherwise.

Other tests are done after a meal or after a substance that encourages insulin release. These are called stimulated C-peptide tests. Do not fast for one of these unless specifically instructed.

Tell the testing team about all prescription medicines, over-the-counter products, and supplements you take. Do not stop insulin or any other diabetes medicine unless the clinician supervising the test has given you a specific plan. Changing these medicines without guidance can be unsafe and can make the result difficult to interpret.

What happens during the test

For a standard test, a healthcare professional places a small needle into a vein, usually in your arm. A tube of blood is collected and may be sent with a blood glucose sample. The blood draw usually takes only a few minutes.

For a stimulated test, you may drink a standard liquid meal or receive a medicine such as glucagon that encourages the pancreas to release insulin. Blood samples are then collected at set times. This appointment takes longer and may cause temporary nausea, particularly when glucagon is used.

C-peptide can also be measured in urine, but blood testing is more common. Timed urine collections are affected by kidney function and by whether the full collection was completed.

Understanding your results

There is no single universal C-peptide reference range. Laboratories use different methods and may report results in different units. Interpretation also varies with age, sex, pregnancy status, kidney function, medicines, blood glucose, and the clinical situation.

A higher result usually means your pancreas is producing more insulin. This may be a normal response after eating or when blood glucose is high. It can also occur with insulin resistance, when the body needs more insulin than usual to control glucose.

A lower result usually means the pancreas is producing little insulin. However, C-peptide can also be low when you have been fasting, when blood glucose is already low, or after injected insulin has lowered your glucose and reduced the pancreas's own insulin release.

The timing matters. During low blood glucose, even a C-peptide result within the laboratory's usual range may be higher than expected because insulin production should normally switch off. Conversely, a low result during low glucose may be an appropriate response.

C-peptide alone cannot confirm a diabetes type, an insulin-producing tumour, or the cause of low blood glucose.

What affects the results

Several factors can change C-peptide without indicating a new problem with pancreatic insulin production.

Kidney function has the greatest practical effect. The kidneys remove C-peptide from the blood, so reduced kidney function can produce a higher result than expected.

Eating raises glucose and usually increases C-peptide. This is why a fasting result should not be compared directly with one taken after a meal. Recent vigorous exercise may lower glucose or change insulin needs, which can also alter the result.

Medicines that encourage the pancreas to release insulin, including sulfonylureas and meglitinides, can raise C-peptide. Injected insulin does not directly add C-peptide, but it can indirectly lower the result by reducing blood glucose and suppressing the pancreas's insulin release.

Other influences include:

  • acute illness, stress hormones, or very high blood glucose
  • pregnancy-related changes in insulin needs
  • age and the duration or type of diabetes
  • pancreatic surgery or a pancreas transplant
  • high-dose biotin supplements with some laboratory methods

A recent blood transfusion, iron deficiency, and altered red blood cell turnover can strongly affect tests such as HbA1c, but they do not usually affect C-peptide directly. Always mention supplements and recent medical procedures so the result can be interpreted in context.

Accuracy and limitations

C-peptide generally reflects the body's own insulin production, but no single accuracy percentage applies to every use. Results differ by laboratory method, timing, blood glucose level, and the cutoff chosen.

The test can appear falsely reassuring if it is used alone. People with early autoimmune diabetes may still produce a meaningful amount of insulin, while people with long-standing type 2 diabetes may eventually produce very little. There is overlap between diabetes types.

Reduced kidney function can make C-peptide look higher than the pancreas's actual production. Fasting, low glucose, or recent injected insulin can make it look lower. Some laboratory tests may also be affected by biotin or other assay-specific interference.

When unexplained hypoglycaemia is being investigated, C-peptide is best measured during the low-glucose episode alongside glucose, insulin, proinsulin, ketones, and testing for medicines that stimulate insulin release. When the question is whether you have diabetes, glucose or HbA1c is the better test.

Risks and complications

A blood draw may cause brief discomfort, a small bruise, or light-headedness. Serious complications are uncommon.

A stimulated test may cause short-lived nausea or flushing, depending on the substance used. The testing service should explain any additional risks before the procedure.

What happens next

Your result should be reviewed with the blood glucose measured at the same time, your kidney function, medicines, and the circumstances of the test.

Routine follow-up may include repeating the test under fasting or stimulated conditions, checking diabetes-related blood tests, or reviewing whether your current treatment matches your insulin production.

An unusual C-peptide result by itself is not generally an emergency. Seek urgent medical help for symptoms of severe low blood glucose, such as confusion, a seizure, or loss of consciousness. Persistent vomiting, marked drowsiness, or difficulty breathing with very high glucose also requires urgent assessment.

Common questions

Can I drink coffee before a C-peptide test?

If you have been told to fast, avoid coffee, including black coffee, because caffeine may affect glucose and hormone responses. Plain water is usually allowed. If the test is not fasting, follow the instructions you were given.

Does the time of day matter?

Time of day is less important than whether you have eaten, your current glucose level, and when you took diabetes medicines. Repeat tests are easier to compare when performed under similar conditions.

Can I exercise beforehand?

Avoid unusually vigorous exercise before the test unless told otherwise. Exercise can change blood glucose and insulin release. Normal daily activity is generally reasonable.

Should I take my insulin or diabetes tablets?

Do not change or skip them on your own. The correct plan depends on whether the test is fasting, stimulated, or being performed during supervised investigation of low glucose.

Can injected insulin raise my C-peptide?

No. Injected insulin contains no C-peptide. It may indirectly lower C-peptide if it lowers your glucose enough to reduce your pancreas's own insulin release.

Is a normal C-peptide result always reassuring?

Not necessarily. A result must be appropriate for your blood glucose at that moment. During low glucose, a seemingly normal C-peptide may be unexpectedly high; during fasting, a lower value may be expected.

Sources

  1. 1C-Peptide TestMedlinePlus Medical Test
  2. 2Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabetic Medicine. 2013;30(7):803–817
  3. 3Leighton E, Sainsbury CAR, Jones GC. A practical review of C-peptide testing in diabetes. Diabetes Therapy. 2017;8:475–487
  4. 4Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults: an ADA and EASD consensus report. Diabetologia. 2021;64:2609–2652
  5. 5Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism. 2009;94(3):709–728

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Insulin c-peptide test; [reviewed 2026 Aug 24; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/tests/insulin-c-peptide-test

APA 7th

sofidex. (2026, August 24). Insulin c-peptide test. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/tests/insulin-c-peptide-test

AMA 11th

Insulin c-peptide test. sofidex. Reviewed August 24, 2026. Accessed November 10, 2026. https://sofidex.com/patients/tests/insulin-c-peptide-test

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.